A USD 90 Million Upfront Anchors Hong Kong Biotech's December RushGlobal Report·Oct 28, 2026 at 03:45 AM02269-3.59%02268-2.08%
Hong Kong's AI-pivot small caps run into the delivery testGlobal Report·Oct 21, 2026 at 10:51 AM07311+2.54%06067-0.21%
Biotech Reality Check: Profit Pioneers vs. Sector Misfits in Hong Kong's 2026 Healthcare RallyGlobal Report·Oct 21, 2026 at 09:16 AM02285-2.74%02552+1.69%
3 Stocks Retail Investors Are Watching In Oral GLP 1 Weight Loss DrugsSimplywall·Oct 16, 2026 at 07:17 PM02552+1.69%
The Signal for Hong Kong's Leftover Small Caps Comes From AbroadGlobal Report·Oct 13, 2026 at 10:51 AM02668+7.27%02552+1.69%
Aluminum and AI Drive Hong Kong Small-Cap Earnings DivergenceGlobal Report·Oct 13, 2026 at 09:24 AM00901+2.42%02788-6.06%
Goodbaby's Buyout Signals a Hong Kong Small-Cap CleanupGlobal Report·Oct 6, 2026 at 10:49 AM00881-2.47%01258-2.39%
Weekly Recap | HUA MEDICINE-B +1.08%, consensus target above spotWeekly Review·Oct 3, 2026 at 05:31 AM02552+1.69%
Property Stimulus Lifted Two of Hong Kong's Long-Tail Names. Guoquan Kept Falling.Global Report·Sep 29, 2026 at 10:51 AM01003-3.00%09663+20.83%
Hong Kong Market Overhaul: Key Moves From Tech ETFs to Consumer PlaysGlobal Report·Sep 22, 2026 at 11:32 AM02648-1.75%07299-5.06%
Hong Kong's Cross-Border Recalibration: Sectoral Divergence Amid Global Macro ShiftsGlobal Report·Sep 22, 2026 at 10:14 AM00302+1.35%01277+0.31%
Survival Check for HK's Fringe Stocks: Who is Actually Making Money?Global Report·Sep 22, 2026 at 09:20 AM02552+1.69%099850.00%
Guoyuan Securities (HK) Sticks to Their Buy Rating for Hua Medicine (HUMDF)Tip Ranks·Sep 22, 2026 at 05:05 AM02552+1.69%
Zhenro's Debt Reckoning and Wuling's Autonomous PushGlobal Report·Sep 15, 2026 at 11:32 AM02552+1.69%00290+7.08%